Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

12th World ADC London 2022

Evvnt Promotion / evvnt
Archivio
-
29.03.2022 - 01.04.2022  Hotel Novotel London West, International Ctre, 1 Shortlands, Hammersmith, W6 8DR London, United Kingdom
Time: 08:00 to 16:00
 
Temi della conferenza
With the approvals of Zynlonta and Tivdak within the last 12 months there are now 11 commercially available ADCs on the market. Furthermore, recent Enhertu and Polivy data suggests that ADCs could be soon be used as earlier line treatments to improve patient outcomes sooner. Undoubtedly, the momentum and inspiration that ADCs and ADC developers are gathering means that it's an incredibly exciting time for the entire community.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URLs:
Brochure: https://go.evvnt.com/944846-3?pid=4832
LinkedIn: https://go.evvnt.com/944846-4?pid=4832
Twitter: https://go.evvnt.com/944846-5?pid=4832

Speakers: Sunil Verma, Global Head and Head of Breast Cancer Strategy, AstraZeneca, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/944846-2?pid=4832
Mr. Hanson Wade
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
GBP 1999.00 - GBP 4495.00
I partecipanti attesi
1000 - 1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAlumni Club Medizinische Universität WienHelix - Forschung & Beratung WienÄrztekammer für WienAnästhesie in Entwicklungsländern e. V.Ärzte der WeltEuropean Health Forum GasteinCharité International Academy